Skip to main content
Izotropic Corporation logo

Izotropic Corporation — Investor Relations & Filings

Ticker · IZO ISIN · CA46604F1099 LEI · 529900IZ5PIVM7X6S027 CSE Manufacturing
Filings indexed 368 across all filing types
Latest filing 2023-02-23 Regulatory Filings
Country CA Canada
Listing CSE IZO

About Izotropic Corporation

https://izocorp.com/

Izotropic Corporation develops and commercializes diagnostic medical devices, specializing in advanced breast cancer detection technology. Its flagship product is IzoView, a dedicated Breast CT imaging platform. IzoView utilizes high-resolution, true 3D imaging without requiring breast compression, offering superior spatial resolution compared to traditional modalities. The system is purpose-built to improve diagnostic accuracy and patient comfort, particularly targeting the 50% of women with dense breast tissue where conventional screening tools are often inadequate. Izotropic is currently advancing IzoView through pivotal clinical studies toward product launch and commercialization.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release from Izotropic Corporation dated February 23, 2023. It contains statements from technical and scientific team members advocating for the commercialization of breast CT technology. The content focuses on promoting the technology, clinical study design, and forward-looking statements about the company's plans and expectations. There are no financial statements, regulatory filings, voting results, or management changes. The document is a corporate news release aimed at investors and the public, not a formal financial report or regulatory filing. Therefore, it fits best under the category of a general regulatory announcement or news release, which corresponds to Regulatory Filings (RNS). The document length (7663 characters) and content confirm it is not a report publication announcement or a detailed financial report.
2023-02-23 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release announcing that Izotropic Corporation's breast CT device will be featured on a TV show. It contains promotional and informational content about the product and the company's plans, but it does not include any financial data, regulatory filings, or report attachments. There is no indication of financial results, management changes, voting results, or other specific report types. The document is a corporate news announcement intended for public and investor information, not a formal financial or regulatory report. Therefore, it fits best under the category of Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2023-01-13 English
News release - English.pdf
Remuneration Information Classification · 95% confidence The document is a news release announcing the creation of a Compensation Committee and the adoption of its charter by Izotropic Corporation. It details the committee's roles, responsibilities, and members. There is no financial data, no report attached or referenced as being published, and no mention of voting results or regulatory filings. The content focuses on governance-related information about board committee structure and compensation oversight. Therefore, the document fits best under 'Remuneration Information' (DEF 14A), which covers reports detailing compensation for top executives and directors, including committee formation and charters related to compensation.
2023-01-12 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a news release from Izotropic Corporation announcing the release of the first video showcasing their breast CT imaging platform, IzoView. It includes statements from company executives and a co-founder, describing the technology and its significance. There are no financial statements, regulatory filings, voting results, or management changes. The content is promotional and informational about a product milestone and upcoming presentations, not a financial report or regulatory filing. It does not fit categories like Annual Report, Earnings Release, or Investor Presentation. It is a news release about a product update and company milestone, which aligns best with a Regulatory Filings (RNS) category as a general announcement that does not fit other specific categories.
2023-01-09 English
Material change report - English.pdf
Board/Management Information Classification · 95% confidence The document is titled '51-102F3 MATERIAL CHANGE REPORT' and details changes in the company's management, specifically the resignation of the CFO and appointment of an interim CFO and COO. It includes a news release reporting the results of a board meeting focused on management changes and strategic direction. There are no financial statements or detailed financial performance data present. The content is primarily about changes in senior management and board-related announcements. Therefore, the document fits the category of 'Board/Management Information' (MANG). The document length (8843 characters) is sufficient to be a full announcement rather than a brief notice or report publication announcement. Hence, the classification is MANG with high confidence.
2023-01-05 English
News release - English.pdf
Board/Management Information Classification · 100% confidence The document is a news release reporting the results of a board meeting held on December 29, 2022. It announces changes in senior management positions, including the appointment of a new COO, the departure of the CFO, and the appointment of an interim CFO, as well as changes in responsibilities related to investor relations and communications. The content focuses on management changes and strategic direction rather than financial results or detailed financial data. There is no indication of financial statements, audit information, or regulatory filings. The document fits the description of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2023-01-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.